June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Breast, Cervical and Colorectal Cancer Screening among Canadians with and without Self-Reported Visual Impairment
Author Affiliations & Notes
  • Milena Cioana
    Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  • James H.B. Im
    Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
  • Yvonne Buys
    Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Hatem Krema
    Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Sophia Liu
    Department of Family Medicine, Western University Schulich School of Medicine & Dentistry, London, Ontario, Canada
  • Peng Yan
    Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Yaping Jin
    Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
    Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Milena Cioana None; James Im None; Yvonne Buys None; Hatem Krema None; Sophia Liu None; Peng Yan None; Yaping Jin None
  • Footnotes
    Support  Dr. John P. Mitchell (cancer) Award and the Lindenfield Family Grant
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2630. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Milena Cioana, James H.B. Im, Yvonne Buys, Hatem Krema, Sophia Liu, Peng Yan, Yaping Jin; Breast, Cervical and Colorectal Cancer Screening among Canadians with and without Self-Reported Visual Impairment. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2630.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cancer screening can lead to early detection and reduced mortality. Due to barriers in reading, driving, and ambulating, individuals with visual impairment (VI) may participate in cancer screening less often than those without VI. This cross-sectional study compared participation rates in government-funded screening for breast, cervical and colorectal cancer in Canadians with and without VI, and examined associated sociodemographic factors.

Methods : Self-reported data on vision status and participation in mammography, pap smear, and fecal occult blood test was analyzed from the Canadian Community Health Survey 2013/2014 and 2017/2018. Participation in screening at the recommended age and time interval was compared between individuals with and without VI. Screening rates were also compared by level of household income and education, and having a family physician.

Results : Canadians with VI had lower participation rates in breast (53.0% [95% confidence interval [CI] 36.3-69.7%] vs. 67.0% [95% CI 64.5-69.4%]) and cervical (53.8% [95% CI 29.3-78.3%] vs. 76.2% [95% CI 74.0-78.3%]) cancer screening versus those without VI in 2013/2014. Colorectal cancer screening rates were similar for participants with and without VI (25.7% [95% CI 17.3-34.1%] vs. 24.7% [95% CI 23.7-25.6%]). Differences between the VI and non-VI groups across the three cancer screening categories persisted despite having a family physician. Lower levels of household income and education were associated with lower screening rates in the VI group for all cancer screenings examined. The 2017/2018 data similarly revealed a lower breast cancer (61.9% [95% CI 55.7-68.2%] vs. 69.4% [95% CI 66.3-72.5%]) and a comparable colorectal cancer screening rate (40.7% [95% CI 37.0-44.5%] vs. 38.0% [95% CI 36.4-39.5%]) in Canadians with versus without VI. Information on cervical cancer screening was unavailable in 2017/2018.

Conclusions : Canadians with self-reported VI appear to have lower participation rates in breast and cervical cancer screening than those without VI. Having a family physician did not impact the noticed lower participation rate. Smaller sample sizes in individuals with VI are likely responsible for the wide CI and non-significant differences observed. Policy-makers, organizations and clinicians should understand the unique barriers faced by individuals with VI, and facilitate adherence to screening guidelines.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×